Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:04 pm Sale | 2024-09-30 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 2,742,936 6.200% | -519,564 (-15.93%) | Filing History |
| 2024-11-14 4:04 pm Sale | 2024-09-30 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 3,398,747 7.800% | -69,430 (-2.00%) | Filing History |
| 2024-11-14 4:03 pm Sale | 2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,306,671 4.800% | -2,174,093 (-33.55%) | Filing History |
| 2024-10-22 4:02 pm Unchanged | 2024-10-15 | 13G | Bright Minds Biosciences Inc. DRUG | PFM Health Sciences LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | PFM Health Sciences LP | 656,548 0.500% | 471,384 (+254.58%) | Filing History |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | bluebird bio, Inc. BLUE | PFM Health Sciences LP | 102,133 1.900% | -198,960 (-66.08%) | Filing History |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 6,480,764 7.300% | 2,020,981 (+45.32%) | Filing History |
| 2024-02-14 4:06 pm Sale | 2023-12-31 | 13G | ESSA Pharma Inc. EPIX | PFM Health Sciences LP | 3,262,500 7.400% | -581,832 (-15.13%) | Filing History |
| 2024-02-14 4:06 pm Purchase | 2023-12-31 | 13G | Werewolf Therapeutics, Inc. HOWL | PFM Health Sciences LP | 3,468,177 9.600% | 1,646,357 (+90.37%) | Filing History |
| 2023-04-21 4:08 pm Purchase | 2023-04-11 | 13G | bluebird bio, Inc. BLUE | PFM Health Sciences LP | 301,092 5.700% | 301,092 (New Position) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | IO Biotech, Inc. IOBT | PFM Health Sciences LP | 507,640 1.800% | -1,002,496 (-66.38%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Generation Bio Co. GBIO | PFM Health Sciences LP | 2,903,192 4.900% | -110,520 (-3.67%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Jounce Therapeutics, Inc. JNCE | PFM Health Sciences LP | 345,926 0.700% | -3,626,942 (-91.29%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Outset Medical, Inc. OM | PFM Health Sciences LP | 0 0.000% | -2,940,255 (Position Closed) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Adaptimmune Therapeutics plc ADAP | PFM Health Sciences LP | 29,061,060 3.000% | -25,597,620 (-46.83%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | PFM Health Sciences LP | 185,164 5.900% | 19,862 (+12.02%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | PFM Health Sciences LP | 2,703,287 3.700% | -1,229,946 (-31.27%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | uniQure N.V. QURE | PFM Health Sciences LP | 2,302,314 4.900% | -90,997 (-3.80%) | Filing History |
| 2023-02-14 4:06 pm Purchase | 2022-12-31 | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,459,783 7.300% | 367,474 (+8.98%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Erasca, Inc. ERAS | PFM Health Sciences LP | 4,797,460 3.200% | -2,953,028 (-38.10%) | Filing History |